Company Overview and News

 
Appointments

2018-04-28 aviationweek
Russell Hubbard has been appointed director of aircraft remarketing for Air Partner Remarketing. He was senior vice president of aircraft trading for the China Aircraft Leasing Group in Hong Kong. Stephen Polk has joined Jet Linx as the base partner of Jet Linx Detroit. He is an investor in the Detroit base and president and CEO of Highgate, a private investment company. Bill Yantiss has been named chief operating officer of Argus International, while John Illson has been promoted to .

 
Appointments

2018-04-28 aviationweek
Russell Hubbard has been appointed director of aircraft remarketing for Air Partner Remarketing. He was senior vice president of aircraft trading for the China Aircraft Leasing Group in Hong Kong. Stephen Polk has joined Jet Linx as the base partner of Jet Linx Detroit. He is an investor in the Detroit base and president and CEO of Highgate, a private investment company. Bill Yantiss has been named chief operating officer of Argus International, while John Illson has been promoted to .

 
CALC Strikes Deal With Viva For Airbus A320s

2018-01-05 aviationweek
China Aircraft Leasing Group (CALC) has concluded a purchase-and-leaseback agreement with Latin American LCC group Viva Air for five Airbus A320ceo aircraft. The aircraft are scheduled to be delivered in 2018–19, and the transaction marks CALC’s initial entry into Viva Air’s Colombian and Peruvian markets. The Viva Air group is based in Panama. “In recent years, the aviation market in Latin America has flourished due to the increase in travel and tourism,” .

 
China Aircraft Leasing buys another 15 Airbus A320 jets, taking order size to US$7.5 billion

2018-01-05 scmp
China Aircraft Leasing Group (CALC) has agreed to buy an additional 15 Airbus A320neo jets on top of the 55 ordered in December, as it increases its fleet to meet the growing demand for air travel in China, which is set to overtake the US as the world’s largest market.

 
Hong Kong given level playing field after government cuts tax rate on aircraft leasing companies

2017-07-30 scmp
With the recent decision by the Hong Kong government to cut the tax rate on aircraft leasing companies, analysts and industry insiders believe the city has an opportunity to be less reliant on property and tourism when it comes to financial transactions.

 
China Aircraft Leasing seeks overseas customers with aggressive fleet expansion

2017-07-13 scmp
Aircraft leasing could be an economic driver for Hong Kong, which relies too heavily on its property market, says chief executive

 
Boeing, CALC Announce Order for 50 737 MAXs

2017-06-21 asdnews
Boeing [NYSE: BA] and China Aircraft Leasing Group (CALC) [SEHK stock code: 01848 HK] today announced an order for 50 737 MAX airplanes at the 2017 Paris Air Show.

 
China’s CALC joins line-up for Boeing 737 MAX 10, say sources

2017-06-18 themalaymailonline
PARIS, June 18 — A model aircraft is displayed at the reception of the China Aircraft Leasing Group office in Hong Kong June 22, 2015. — Reuters pic China Aircraft Leasing Group Holdings (CALC) is among the inaugural customers for a larger new version of Boeing’s 737 jetliner, two industry sources said yesterday.

 
China Aircraft Leasing says 2016 profits likely to be up 60pc

2017-02-20 scmp
China Aircraft Leasing Group (CALC), one of the country’s biggest aircraft lessors, said its net profits for 2016 would leap at least 60 per cent from a year earlier, as its business expansion pays off.

1
Commercial Aircraft Disassembly, Dismantling & Recycling Market Report 2016-2026

2016-09-23 prnewswire
Leading Companies in Aircraft Storage, Aircraft Disassembly, Engine Teardown & Component Management, Fleet Analysis Covering 49 Carriers Globally, Carbon Composite Recycling Capabilities And Passenger-To-Freight Conversion (PFC) Technology 

 
Wall Street Breakfast: Apple Heads To Trial Over iTunes Update

2016-09-18 seekingalpha
Economy Chinese stocks staged a late rally today amid speculation of more stimulus from the country's central bank. The Shanghai Composite Index climbed 3.1%, while the Hang Seng benchmark rose 1.2%. Oil has resumed declines as commodity volatility hit a two-year high, after yesterday’s 4.3% surge. WTI crude is down 1.6% at $67.90/barrel.

 
Indonesian airline will be first to fly fleet entirely of ARJ21s

2016-07-12 scmp
Comac signs 60-jet deal with Hong Kong leasing group, worth up to US$2.3 billion — largest single order yet for the Chinese-built airliner

 
Comac signs 60-jet deal with Hong Kong leasing group, worth up to US$2.3 billion

2016-07-12 scmp
An Indonesian airline is to become the world’s first to operate a fleet made up entirely of Chinese-built jets.

 
China's Comac lands $2.3B order for homegrown ARJ21 jet

2016-07-12 nzherald.co.nz
HONG KONG (AP) " China's state-owned aircraft maker has signed a deal to sell up to 60 of its new regional jets to a leasing company in a deal worth up to $2.3 billion.

 
China's Comac lands $2.3B order for homegrown ARJ21 jet

2016-07-12 ctvnews.ca
In this June 28, 2016, file photo, people wave Chinese flags and take photos as a Chengdu Airlines ARJ21-700 regional jet is taxied after landing at the Hongqiao Airport in Shanghai. (Chinatopix via AP, File)

Related Articles

HRTX : Heron Therapeutics Analysis and Research Report

2018-05-25 - Asif

Overview Heron is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments that address some of the most important unmet patient needs. Heron Therapeutics is developing novel, patient-focused solutions that apply its innovative science and technologies to already approved pharmacological agents for patients suffering from cancer or pain. On August 9, 2016, its first commercial product, SUSTOL, was approved by the FDA. The company developed SUSTOL for the prevention of chemotherapy-induced nausea and vomiting (“CINV”). SUSTOL is indicated, in combination with other antiemetics, in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy (“MEC”) or anthracycline and cyclophosphamide (“AC”) combination chemotherapy regimens. The company commenced commercial sales of SUSTOL in the U.S. in October 2016. On November 9, 2017...

ACIA: Acacia Communications Analysis and Research Report

2018-05-25 - Asif

Overview The company's mission is to deliver high-speed coherent optical interconnect products that transform communications networks, relied upon by cloud infrastructure operators and content and communication service providers, through improvements in performance and capacity and reductions in associated costs. By converting optical interconnect technology to a silicon-based technology, a process the company refer to as the siliconization of optical interconnect, the company believe Acacia Communications is leading a disruption that is analogous to the computing industry’s integration of multiple functions into a microprocessor. The company's products include a family of low-power coherent digital signal processor application-specific integrated circuits, or DSP ASICs, and silicon photonic integrated circuits, or silicon PICs, which Acacia Communications has integrated into families of optical interconnect modules with transmission speeds ranging from 100 to 400 gigabits per ...

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...